Vortioxetine for Cognitive Impairment in Major Depressive Disorder During Post-COVID Syndrome
<b>Conclusion:</b> Vortioxetine has a significant procognitive effect. Antidepressant effects and improvement in fatigue symptoms (PROMIS 7a) also were observed.
Authors
- Angela T.H. Kwan (ORCID: https://orcid.org/0000-0003-4013-1112)
- Juan F. Gálvez‐Flórez
- Sergio Moreno (ORCID: https://orcid.org/0000-0002-3043-0963)
- Juan‐Manuel Anaya (ORCID: https://orcid.org/0000-0002-6444-1249)
- Hernan Felipe Guillen-Burgos (ORCID: https://orcid.org/0000-0003-1835-431X)
- Roger S. McIntyre (ORCID: https://orcid.org/0000-0003-4733-2523)
Institutions
- University Health Network (CA)
- University of Ottawa (CA)
- Universidad de Los Andes (CO)
- University of Toronto (CA)
- Universidad El Bosque (CO)
- Pontificia Universidad Javeriana (CO)
Publication Details
- Journal
- The Journal of Clinical Psychiatry
- Published
- 2025-05-05
- DOI
- https://doi.org/10.4088/jcp.24m15387
- Citations
- 1
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 1.39